• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vericel Corporation - Common Stock (NQ:VCEL)

33.46 -1.67 (-4.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vericel Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Vericel Corp (NASDAQ:VCEL): A Prime Example of Affordable Growth ↗
Today 7:20 EDT
Via Chartmill
News headline image
Vericel Q1 Earnings Call Highlights ↗
Today 2:07 EDT
Vericel (NASDAQ:VCEL) reported record first-quarter revenue and raised its full-year 2026 outlook, citing strong growth across its MACI cartilage repair franchise and Burn Care business, as well as... 
Via MarketBeat
Topics Earnings
News headline image
Vericel (VCEL) Q1 2026 Earnings Transcript ↗
May 08, 2026
Vericel (VCEL) Q1 2026 Earnings Transcript 
Via The Motley Fool
Vericel Corp (NASDAQ:VCEL) Smashes Q1 Estimates, Raises Full-Year Outlook as MACI and Burn Care Surge ↗
May 07, 2026
Via Chartmill
News headline image
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
May 07, 2026
From Vericel Corporation
Via GlobeNewswire
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Technical Setup Opportunity ↗
May 05, 2026
Via Chartmill
Vericel Corp (NASDAQ:VCEL) Emerges as a Top Affordable Growth Pick ↗
March 27, 2026
Via Chartmill
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Breakout Case ↗
February 27, 2026
Via Chartmill
Vericel Corp (NASDAQ:VCEL) Reports Q4 2025 Earnings In Line, Beats on Profitability ↗
February 26, 2026
Via Chartmill
News headline image
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
April 23, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
April 02, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid
April 02, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility
March 04, 2026
From Vericel Corporation
Via GlobeNewswire
Vericel Corp (NASDAQ:VCEL) Presents a Strong Growth and Breakout Setup ↗
February 06, 2026
Via Chartmill
Vericel Corp (NASDAQ:VCEL) Emerges as a Prime GARP Investment Candidate ↗
February 03, 2026
Via Chartmill
VERICEL CORP (NASDAQ:VCEL) Fits the "Growth at a Reasonable Price" Profile ↗
January 01, 2026
Via Chartmill
News headline image
Vericel to Present at Multiple Upcoming Investor Conferences
March 03, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel (VCEL) Q4 2025 Earnings Call Transcript ↗
February 26, 2026
Vericel (VCEL) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 26, 2026
February 12, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Why Is Vericel Stock Gaining Tuesday? ↗
January 13, 2026
Vericel Corporation (NASDAQ: VCEL) stock rose on Tuesday after announcing preliminary financial results for 2025. 
Via Benzinga
News headline image
Vericel Announces Preliminary 2025 Financial Results and Business Updates
January 13, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026
January 06, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Corp. (NASDAQ:VCEL) Presents a High-Growth Profile with a Technical Setup for a Potential Breakout ↗
December 15, 2025
Vericel Corp. (VCEL) combines strong revenue growth and accelerating earnings with a technical setup suggesting a potential price breakout from a key support level. 
Via Chartmill
News headline image
Vericel Corp (NASDAQ:VCEL) Emerges as a Top GARP Investment Candidate ↗
December 11, 2025
Vericel Corp (VCEL) exemplifies GARP investing with strong growth, high profitability, and a valuation reasonable for its biotech sector. 
Via Chartmill
News headline image
Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025
November 14, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Corp (NASDAQ:VCEL) Emerges as a Top Affordable Growth Candidate ↗
November 12, 2025
Vericel (VCEL) offers affordable growth in biotech with strong revenue & earnings, solid financials, and a reasonable valuation relative to peers. 
Via Chartmill
News headline image
Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings ↗
November 06, 2025
Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Vericel (VCEL) Q3 2025 Earnings Call Transcript ↗
November 06, 2025
Vericel (VCEL) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Vericel Corporation (NASDAQ:VCEL) Surpasses Earnings Estimates with Strong Q3 2025 Results ↗
November 06, 2025
Vericel (VCEL) beats Q3 2025 earnings estimates with strong revenue growth and a swing to profitability, driven by its MACI and burn care products. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap